16.1
C
Manchester
Trending now
SpaceX’s Record-Breaking IPO Draws Massive Market Attention:…
Craig Plescia Debunks Five Myths Holding Back…
Rootstack Panama launches Keep Learning Pledge for…
Donald Deibler: Why Your Local Business Matters…
Tabber Benedict Debunks 5 Legal Myths That…
Larry Michael Baum Launches “Build Forward” Responsible…
NFL Player to Host Free Youth Football…
Rallying economic indicators should lead to jobs
RX Pros Launches 7-Day “Access Action” Challenge…
Carziqo Extends Relief Support to Earthquake-Affected Communities…
Home
News
Business
National
Press Release
Finanace
Search for:
Search
Primary Menu
Search for:
Search
Home
Business
FDA vaccine head will step down in April after string of controversial decisions
Business
FDA vaccine head will step down in April after string of controversial decisions
by
Douglas L. Grider
Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.
previous post
FDA reversals leave investors worrying about the fates of other experimental drugs
next post
[TEST DRIVE] Renault Korea’s Filante set to take on Santa Fe, Sorento
Douglas L. Grider
Related posts
United Airlines CEO confirms he approached American Airlines about merger
Douglas L. Grider
April 27, 2026
Walmart to report first-quarter earnings before the bell. Here’s what Wall Street expects
Douglas L. Grider
May 21, 2026
Jamie Dimon says Trump’s $5 billion debanking lawsuit ‘has no merit’ but he’s sympathetic to concerns
Douglas L. Grider
March 2, 2026